Skip to main content
ABVC
NASDAQ Life Sciences

ABVC Sets October 28 Vote on 5.2M-Share Equity Plan and Related-Party Land Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.03
Mkt Cap
$32.089M
52W Low
$0.707
52W High
$3.4
52W Position info
46% above low
Off High info
70% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ABVC sits 46% above its 52-week low of $0.707.

Summary

ABVC's final proxy sets an October 28 special meeting to vote on a new equity incentive plan with a ~5.17M-share pool, ratification of 600,000 advisor shares, and a related-party land acquisition from a Board member for up to 1.6M shares.


Key Events · Corporate Governance and Compliance · ABVC

  • Special Meeting Set for October 28

    Shareholders of record as of September 14, 2026 will vote on three proposals at a virtual meeting; 26,694,476 shares are outstanding and entitled to vote.

  • 2026 Equity Incentive Plan Pool

    The new plan would reserve 1,169,201 shares plus 15% of shares outstanding on the meeting date — an illustrative 5,173,372 shares — with a 5% annual evergreen increase beginning January 1, 2027.

  • Related-Party Land Acquisition

    Proposal 3 authorizes up to 1,600,653 shares at no less than $1.00 per share to acquire Taiwan properties from Board member Shuling Jiang, who currently owns 3,735,572 shares (~14%) and could reach ~18.86% if the maximum is issued.

  • Independent Appraisal Values

    ZMRE appraised the Taoyuan Lands at NT$10,948,541 (~US$339,048) and the Hualien Property at NT$9,146,467 (~US$283,243), for an aggregate of NT$20,095,008 (~US$622,291); the final purchase price remains subject to negotiation.


Analysis · ABVC · Life Sciences

ABVC BioPharma's definitive proxy finalizes three shareholder votes for a special meeting on October 28, 2026. The 2026 Equity Incentive Plan would create an award pool of roughly 5.17 million shares — about 19% of the 26.7 million shares outstanding — with an automatic 5% annual top-up starting in 2027. The land acquisition from Board member Shuling Jiang would issue up to 1.6 million shares at no less than $1.00 per share, potentially lifting her stake from 14% to nearly 19%. Independent appraisals value the Taiwan properties at about US$622,000, but the final purchase price and share count remain unnegotiated. Against a backdrop of minimal cash and a going-concern warning from the Q2 10-Q, these equity-based transactions represent meaningful potential dilution for existing holders.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ABVC was trading at $1.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32.1M. The 52-week trading range was $0.71 to $3.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ABVC - Latest Insights

ABVC
Nov 10, 2026, 6:20 PM EST
Filing Type: S-3/A
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.9499 info
Change: -$0.0501 (-5%) info
Market Cap: $25.625M info
ABVC
Nov 10, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.9499 info
Change: -$0.0501 (-5%) info
Market Cap: $25.625M info
ABVC
Nov 02, 2026, 9:51 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.9499 info
Change: -$0.100 (-10%) info
Market Cap: $25.625M info
ABVC
Nov 02, 2026, 9:30 AM EST
Source: EQS
Importance Score:
7
Price at Filing: $1.04
Real-time Price: $0.9499 info
Change: -$0.0901 (-9%) info
Market Cap: $25.625M info
ABVC
Sep 11, 2026, 4:30 PM EDT
Filing Type: PRER14A
Importance Score:
7
Price at Filing: $1.01
Real-time Price: $0.9499 info
Change: -$0.0601 (-6%) info
Market Cap: $25.625M info